Literature DB >> 20174823

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.

Georgia Levidou1, Angelica A Saetta, Maria Karlou, Irene Thymara, Harris Pratsinis, Petros Pavlopoulos, Dimitrios Isaiadis, Kalliopi Diamantopoulou, Efstratios Patsouris, Penelope Korkolopoulou.   

Abstract

PURPOSE: To elucidate the role of D-type cyclins in both superficial (Ta-T1) and muscle-invasive (T2-T4) urothelial carcinomas (UCs), investigating their potential prognostic usefulness.
METHODS: Paraffin-embedded tissues from 157 patients with bladder UC were immunostained for cyclins D1, D2 and D3.
RESULTS: Cyclin D1 expression positively correlated with D2 and negatively with D3. Cyclin D1 expression decreased with increasing grade (P = 0.0001) and tumour T-category in the entire cohort and in muscle-invasive carcinomas (P = 0.0001 and P = 0.0033). Cyclin D2 correlated with grade (P = 0.0005) and T-category (P = 0.0078), a relationship which remained significant in muscle-invasive (P = 0.0135). Cyclin D3 immunoreactivity increased with histologic grade and T-category in the entire cohort (P = 0.0001 in both relationships), in superficial (P = 0.0034) and in muscle-invasive carcinomas (P = 0.0036, respectively). Survival analysis in superficial tumours showed that higher cyclin D1 (P = 0.0001) and higher cyclin D3 levels (P = 0.0032) were correlated with a lesser probability of survival. In muscle-invasive tumours, lower cyclin D1 (P = 0.0234), and D2 (P = 0.0424) and higher cyclin D3 (P = 0.0322) correlated with shortened survival. In multivariate analysis in superficial tumours only cyclin D3 expression remained significant. Cyclin D3 expression also retained its adverse significance in muscle-invasive tumours.
CONCLUSIONS: Cyclin D1 overexpression seems to be more important during early T-categories of bladder carcinogenesis, whereas cyclin D3 is implicated in the acquisition of a more aggressive phenotype. Cyclin D3 overexpression emerges as an independent adverse prognostic marker in both superficial and muscle-invasive tumours. Cyclin D1 is an independent indicator of shortened survival only in muscle-invasive tumours.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174823     DOI: 10.1007/s00432-010-0814-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.

Authors:  Y Takano; Y Kato; M Masuda; Y Ohshima; I Okayasu
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

2.  Factors influencing the survival of patients with transitional cell tumours of the urinary bladder.

Authors:  J P Pryor
Journal:  Br J Urol       Date:  1973-12

3.  Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.

Authors:  C L Rosenberg; H G Kim; T B Shows; H M Kronenberg; A Arnold
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

4.  Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.

Authors:  R Büschges; R G Weber; B Actor; P Lichter; V P Collins; G Reifenberger
Journal:  Brain Pathol       Date:  1999-07       Impact factor: 6.508

5.  Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.

Authors:  Georgia Levidou; Penelope Korkolopoulou; Irene Thymara; Ioannis Vassilopoulos; Angelica A Saetta; Hariclia Gakiopoulou; Anastasia Konstantinidou; Evi Kairi-Vassilatou; Kitty Pavlakis; Efstratios Patsouris
Journal:  Int J Gynecol Pathol       Date:  2007-10       Impact factor: 2.762

6.  Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1998-08-27       Impact factor: 9.867

7.  Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.

Authors:  Antonio Lopez-Beltran; Rafael J Luque; Jose Alvarez-Kindelan; Ana Quintero; Felix Merlo; Maria J Requena; Rodolfo Montironi
Journal:  Am J Clin Pathol       Date:  2004-09       Impact factor: 2.493

8.  Cyclin D1 and prognosis in human breast cancer.

Authors:  C Gillett; P Smith; W Gregory; M Richards; R Millis; G Peters; D Barnes
Journal:  Int J Cancer       Date:  1996-04-22       Impact factor: 7.396

9.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.

Authors:  M Pagano; A M Theodoras; S W Tam; G F Draetta
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

10.  Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder.

Authors:  Georgia Levidou; Angelica A Saetta; Penelope Korkolopoulou; Polyanthi Papanastasiou; Katerina Gioti; Petros Pavlopoulos; Kalliopi Diamantopoulou; Eupthemia Thomas-Tsagli; Konstantinos Xiromeritis; Efstratios Patsouris
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

View more
  5 in total

Review 1.  Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.

Authors:  Yuanbin Ru; Garrett M Dancik; Dan Theodorescu
Journal:  Curr Opin Urol       Date:  2011-09       Impact factor: 2.309

2.  Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.

Authors:  Saba El-Gendi; Ghada Abu-Sheasha
Journal:  Pathol Oncol Res       Date:  2017-05-09       Impact factor: 3.201

3.  Spotlight on differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Dimitrios Volanis; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

4.  The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.

Authors:  Baoming Ren; Wenjun Li; Yanping Yang; Songdi Wu
Journal:  World J Surg Oncol       Date:  2014-03-06       Impact factor: 2.754

5.  Impact of Cyclin D1 and Heterogeneous Nuclearzzm321990Ribonucleoprotein-K (HnRNP-K) on Urinary Bladderzzm321990Carcinogenesis

Authors:  Tarek Aboushousha; Olfat Hammam; Noha Helal; Samir El Dahshan
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.